Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Avid Bioservices Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Avid Bioservices Inc, Medical Devices Deals, 2012 to YTD 2018 10
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Peregrine Pharma Enters into Research Agreement with National Comprehensive Cancer Network 12
Peregrine Pharma Expands its Agreement with AstraZeneca 13
Peregrine Pharma Enters into Research Agreement with Memorial Sloan Kettering Cancer Center 14
Equity Offering 15
Peregrine Pharma to Raise USD30 Million in Public Offering of Shares 15
Peregrine Pharma to Raise USD12.3 Million in Public Offering of Shares 16
Peregrine Pharma Completes Underwriters Exercise Of Partial Over-Allotment Option Of Public Offering Of Series E Preferred Stock For US$19.4 Million 17
Peregrine Pharma Files Registration Statement For Public Offering Of Securities For US$100 Million 19
Peregrine Pharma Completes Private Placement Of Shares For US$14 Million 20
Peregrine Pharma Files Registration Statement For Private Placement Of Common Stock For US$75 Million 21
Avid Bioservices Inc – Key Competitors 22
Avid Bioservices Inc – Key Employees 23
Avid Bioservices Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Strategy And Business Planning 25
Apr 24, 2018: Avid Bioservices Provides Update on Ongoing Expansion of Process Development Capabilities and Laboratory Infrastructure 25
Jul 31, 2017: Peregrine Provides Strategic Update 26
Financial Announcements 28
Dec 11, 2017: Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments 28
Sep 11, 2017: Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent Developments 31
Jul 14, 2017: Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent Developments 33
Mar 13, 2017: Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2017 and Recent Developments 36
Corporate Communications 38
Dec 26, 2017: Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer 38
Oct 24, 2017: Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices 39
Oct 19, 2017: Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices 40
Sep 11, 2017: Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid Bioservices 41
Aug 11, 2017: Peregrine Announces Measures to Reduce Costs, Facilitate Profitability and Strengthen its Operations 42
Product News 43
May 01, 2017: MilliporeSigma’s Mobius 2,000-liter Single-use Bioreactors to Expand Avid Bioservices’ Manufacturing Capabilities 43
Other Significant Developments 44
Jan 05, 2018: Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO) 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Avid Bioservices Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Avid Bioservices Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Avid Bioservices Inc, Medical Devices Deals, 2012 to YTD 2018 10
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Peregrine Pharma Enters into Research Agreement with National Comprehensive Cancer Network 12
Peregrine Pharma Expands its Agreement with AstraZeneca 13
Peregrine Pharma Enters into Research Agreement with Memorial Sloan Kettering Cancer Center 14
Peregrine Pharma to Raise USD30 Million in Public Offering of Shares 15
Peregrine Pharma to Raise USD12.3 Million in Public Offering of Shares 16
Peregrine Pharma Completes Underwriters Exercise Of Partial Over-Allotment Option Of Public Offering Of Series E Preferred Stock For US$19.4 Million 17
Peregrine Pharma Files Registration Statement For Public Offering Of Securities For US$100 Million 19
Peregrine Pharma Completes Private Placement Of Shares For US$14 Million 20
Peregrine Pharma Files Registration Statement For Private Placement Of Common Stock For US$75 Million 21
Avid Bioservices Inc, Key Competitors 22
Avid Bioservices Inc, Key Employees 23
List of Figures
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Avid Bioservices Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Avid Bioservices Inc, Medical Devices Deals, 2012 to YTD 2018 10